Professor Ed Lavelle wins Irish Society for Immunology Annual Award 2023
Dr. Ed Lavelle is a Professor of Immunology at Trinity College Dublin, Ireland, where he leads The Adjuvant Research Group, a globally renowned team dedicated to the study and advancement of vaccines.
In 2021, he achieved the distinction of being elected as a member of the Royal Irish Academy (MRIA) in recognition of his remarkable contributions to the field of immunization. He currently serves as the President of the European Congress of Immunology (ECI) for the year 2024 and has previously held the role of President of the Irish Society for Immunization (ISI). Before this, he also served as the Head of the Department of Biochemistry and Immunology at Trinity College Dublin.
Prof. Lavelle earned his Bachelor of Science with Honors in Microbiology from University College Galway and obtained a Doctorate in Immunology from the University of Plymouth. His early career included postdoctoral research positions at the University of Nottingham, Rowett Research Institute, Maynooth University, and Trinity College Dublin, where he focused on vaccine adjuvants and immunomodulation. Subsequently, he joined Trinity College Dublin as a lecturer in 2004, advanced to become an associate Professor in 2012, and was appointed as a full Professor in Immunology in 2015.
Prof. Lavelle's primary research area centers around the development of injectable and mucosal vaccines for infectious diseases and understanding their mechanisms of action. His research group at Trinity College Dublin is also dedicated to creating therapeutic vaccines for cancer and exploring vaccine strategies that induce immunogenic cell death, ultimately leading to enhanced protective immunity.
In recognition of his outstanding contributions to Irish immunology research and education, the Irish Society for Immunology proudly honoured Prof. Lavelle with their Annual Award for Immunization 2022 which was presented to him on the Annual Award ceremony held in Trinity College Tercentenary Hall on May 9th 2023.